Biotechnology: Global Industry Guide

Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Report Highlights
The global biotechnology market grew by 10.6% in 2007 to reach a value of $171,803 million.

In 2012, the market is forecast to have a value of $275,757 million, an increase of 60.5% since 2007.

In value terms, the medical/healthcare segment generated 69.4% of the market value.

In value terms, the Americas generated 53.7% of the market value
[Studien Infos ausblenden]

Table 1: Global Biotechnology Market Value: $ million, 2003-2007 26
Table 2: Global Biotechnology Market Segmentation I: % Share, by Value, 2007 27
Table 3: Global Biotechnology Market Segmentation II: % Share, by Value, 2007 28
Table 4: Global Biotechnology Market Value Forecast: $ million, 2007-2012 35
Table 5: Asia-Pacific Biotechnology Market Value: $ million, 2003-2007 37
Table 6: Asia-Pacific Biotechnology Market Segmentation I: % Share, by Value, 2007 38
Table 7: Asia-Pacific Biotechnology Market Segmentation II: % Share, by Value, 2007 39
Table 8: Asia-Pacific Biotechnology Market Value Forecast: $ million, 2007-2012 46
Table 9: Europe Biotechnology Market Value: $ million, 2003-2007 48
Table 10: Europe Biotechnology Market Segmentation I: % Share, by Value, 2007 49
Table 11: Europe Biotechnology Market Segmentation II: % Share, by Value, 2007 50
Table 12: Europe Biotechnology Market Value Forecast: $ million, 2007-2012 57
Table 13: Europe Exchange Rate, 2003 58
Table 14: Belgium Biotechnology Market Value: $ million, 2003-2007 60
Table 15: Belgium Biotechnology Market Segmentation I: % Share, by Value, 2007 61
Table 16: Belgium Biotechnology Market Segmentation II: % Share, by Value, 2007 62
Table 17: Belgium Biotechnology Market Value Forecast: $ million, 2007-2012 69
Table 18: Belgium Size of Population (million) , 2003-2007 70
Table 19: Belgium GDP (Constant 2000 Prices, $ billion), 2003-2007 70
Table 20: Belgium Inflation, 2003-2007 70
Table 21: Belgium Exchange Rate, 2003 71
Table 22: Canada Biotechnology Market Value: $ million, 2003-2007 73
Table 23: Canada Biotechnology Market Segmentation I: % Share, by Value, 2007 74
Table 24: Canada Biotechnology Market Segmentation II: % Share, by Value, 2007 75
Table 25: Canada Biotechnology Market Value Forecast: $ million, 2007-2012 82
Table 26: Canada Size of Population (million) , 2003-2007 83
Table 27: Canada GDP (Constant 2000 Prices, $ billion), 2003-2007 83
Table 28: Canada Inflation, 2003-2007 83
Table 29: Canada Exchange Rate, 2003 84
Table 30: China Biotechnology Market Value: $ million, 2003-2007 86
Table 31: China Biotechnology Market Segmentation I: % Share, by Value, 2007 87
Table 32: China Biotechnology Market Segmentation II: % Share, by Value, 2007 88
Table 33: China Biotechnology Market Value Forecast: $ million, 2007-2012 95
Table 34: China Size of Population (million) , 2003-2007 96
Table 35: China GDP (Constant 2000 Prices, $ billion), 2003-2007 96
Table 36: China Inflation, 2003-2007 96
Table 37: China Exchange Rate, 2003 97
Table 38: France Biotechnology Market Value: $ million, 2003-2007 99
Table 39: France Biotechnology Market Segmentation I: % Share, by Value, 2007 100
Table 40: France Biotechnology Market Segmentation II: % Share, by Value, 2007 101
Table 41: France Biotechnology Market Value Forecast: $ million, 2007-2012 108
Table 42: France Size of Population (million) , 2003-2007 109
Table 43: France GDP (Constant 2000 Prices, $ billion), 2003-2007 109
Table 44: France Inflation, 2003-2007 109
Table 45: France Exchange Rate, 2003 110
Table 46: Germany Biotechnology Market Value: $ million, 2003-2007 112
Table 47: Germany Biotechnology Market Segmentation I: % Share, by Value, 2007 113
Table 48: Germany Biotechnology Market Segmentation II: % Share, by Value, 2007 114
Table 49: Germany Biotechnology Market Value Forecast: $ million, 2007-2012 121
Table 50: Germany Size of Population (million) , 2003-2007 122
Table 51: Germany GDP (Constant 2000 Prices, $ billion), 2003-2007 122
Table 52: Germany Inflation, 2003-2007 122
Table 53: Germany Exchange Rate, 2003 123
Table 54: Italy Biotechnology Market Value: $ million, 2003-2007 125
Table 55: Italy Biotechnology Market Segmentation I: % Share, by Value, 2007 126
Table 56: Italy Biotechnology Market Segmentation II: % Share, by Value, 2007 127
Table 57: Italy Biotechnology Market Value Forecast: $ million, 2007-2012 134
Table 58: Italy Size of Population (million) , 2003-2007 135
Table 59: Italy GDP (Constant 2000 Prices, $ billion), 2003-2007 135
Table 60: Italy Inflation, 2003-2007 135
Table 61: Italy Exchange Rate, 2003 136
Table 62: Japan Biotechnology Market Value: $ million, 2003-2007 136
Table 63: Japan Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Table 64: Japan Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Table 65: Japan Biotechnology Market Value Forecast: $ million, 2007-2012 136
Table 66: Japan Size of Population (million) , 2003-2007 136
Table 67: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007 136
Table 68: Japan Exchange Rate, 2003 136
Table 69: Netherlands Biotechnology Market Value: $ million, 2003-2007 136
Table 70: Netherlands Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Table 71: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Table 72: Netherlands Biotechnology Market Value Forecast: $ million, 2007-2012 136
Table 73: Netherlands Size of Population (million) , 2003-2007 136
Table 74: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007 136
Table 75: Netherlands Inflation, 2003-2007 136
Table 76: Netherlands Exchange Rate, 2003 136
Table 77: Spain Biotechnology Market Value: $ million, 2003-2007 136
Table 78: Spain Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Table 79: Spain Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Table 80: Spain Biotechnology Market Value Forecast: $ million, 2007-2012 136
Table 81: Spain Size of Population (million) , 2003-2007 136
Table 82: Spain GDP (Constant 2000 Prices, $ billion), 2003-2007 136
Table 83: Spain Inflation, 2003-2007 136
Table 84: Spain Exchange Rate, 2003 136
Table 85: United Kingdom Biotechnology Market Value: $ million, 2003-2007 136
Table 86: United Kingdom Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Table 87: United Kingdom Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Table 88: United Kingdom Biotechnology Market Value Forecast: $ million, 2007-2012 136
Table 89: United Kingdom Size of Population (million) , 2003-2007 136
Table 90: United Kingdom GDP (Constant 2000 Prices, $ billion), 2003-2007 136
Table 91: United Kingdom Inflation, 2003-2007 136
Table 92: United Kingdom Exchange Rate, 2003 136
Table 93: United States Biotechnology Market Value: $ million, 2003-2007 136
Table 94: United States Biotechnology Market Segmentation I: % Share, by Volume, 2007 136
Table 95: United States Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Table 96: United States Biotechnology Market Value Forecast: $ million, 2007-2012 136
Table 97: United States Size of Population (million) , 2003-2007 136
Table 98: United States GDP (Constant 2000 Prices, $ billion), 2003-2007 136
Table 99: United States Inflation, 2003-2007 136
Table 100: Key Facts: Amgen Inc. 136
Table 101: Key Financials: Amgen Inc. 136
Table 102: Key Facts: Genentech, Inc. 136
Table 103: Key Financials: Genentech, Inc. 136
Table 104: Key Facts: Biogen Idec, Inc. 136
Table 105: Key Financials: Biogen Idec, Inc. 136
Figure 1: Global Biotechnology Market Value: $ million, 2003-2007 26
Figure 2: Global Biotechnology Market Segmentation I: % Share, by Value, 2007 27
Figure 3: Global Biotechnology Market Segmentation II: % Share, by Value, 2007 28
Figure 4: Forces Driving Competition in the Global Biotechnology Market, 2007 29
Figure 5: Drivers of Buyer Power in the Global Biotechnology Market, 2007 30
Figure 6: Drivers of Supplier Power in the Global Biotechnology Market, 2007 31
Figure 7: Factors Influencing the Likelihood of New Entrants in the Global Biotechnology Market, 2007 32
Figure 8: Factors Influencing the Threat of Substitutes in the MARKET NAME in COUNTRY, 2007 33
Figure 9: Drivers of Degree of Rivalry in the Global Biotechnology Market, 2007 34
Figure 10: Global Biotechnology Market Value Forecast: $ million, 2007-2012 35
Figure 11: Asia-Pacific Biotechnology Market Value: $ million, 2003-2007 37
Figure 12: Asia-Pacific Biotechnology Market Segmentation I: % Share, by Value, 2007 38
Figure 13: Asia-Pacific Biotechnology Market Segmentation II: % Share, by Value, 2007 39
Figure 14: Forces Driving Competition in the Biotechnology Market in Asia-Pacific, 2007 40
Figure 15: Drivers of Buyer Power in the Biotechnology Market in Asia-Pacific, 2007 41
Figure 16: Drivers of Supplier Power in the Biotechnology Market in Asia-Pacific, 2007 42
Figure 17: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Asia-Pacific, 2007 43
Figure 18: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Asia-Pacific, 2007 44
Figure 19: Drivers of Degree of Rivalry in the Biotechnology Market in Asia-Pacific, 2007 45
Figure 20: Asia-Pacific Biotechnology Market Value Forecast: $ million, 2007-2012 46
Figure 21: Europe Biotechnology Market Value: $ million, 2003-2007 48
Figure 22: Europe Biotechnology Market Segmentation I: % Share, by Value, 2007 49
Figure 23: Europe Biotechnology Market Segmentation II: % Share, by Value, 2007 50
Figure 24: Forces Driving Competition in the Biotechnology market in Europe, 2007 51
Figure 25: Drivers of Buyer Power in the Biotechnology market in Europe, 2007 52
Figure 26: Drivers of Supplier Power in the Biotechnology market in Europe, 2007 53
Figure 27: Factors Influencing the Likelihood of New Entrants in the Biotechnology market in Europe, 2007 54
Figure 28: Factors Influencing the Threat of Substitutes in the Biotechnology market in Europe, 2007 55
Figure 29: Drivers of Degree of Rivalry in the Biotechnology market in Europe, 2007 56
Figure 30: Europe Biotechnology Market Value Forecast: $ million, 2007-2012 57
Figure 31: Belgium Biotechnology Market Value: $ million, 2003-2007 60
Figure 32: Belgium Biotechnology Market Segmentation I: % Share, by Value, 2007 61
Figure 33: Belgium Biotechnology Market Segmentation II: % Share, by Value, 2007 62
Figure 34: Forces Driving Competition in the Biotechnology Market in Belgium, 2007 63
Figure 35: Drivers of Buyer Power in the Biotechnology Market in Belgium, 2007 64
Figure 36: Drivers of Supplier Power in the Biotechnology Market in Belgium, 2007 65
Figure 37: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Belgium, 2007 66
Figure 38: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Belgium, 2007 67
Figure 39: Drivers of Degree of Rivalry in the Biotechnology Market in Belgium, 2007 68
Figure 40: Belgium Biotechnology Market Value Forecast: $ million, 2007-2012 69
Figure 41: Canada Biotechnology Market Value: $ million, 2003-2007 73
Figure 42: Canada Biotechnology Market Segmentation I: % Share, by Value, 2007 74
Figure 43: Canada Biotechnology Market Segmentation II: % Share, by Value, 2007 75
Figure 44: Forces Driving Competition in the Biotechnology Market in Canada, 2007 76
Figure 45: Drivers of Buyer Power in the Biotechnology Market in Canada, 2007 77
Figure 46: Drivers of Supplier Power in the Biotechnology Market in Canada, 2007 78
Figure 47: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Canada, 2007 79
Figure 48: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Canada, 2007 80
Figure 49: Drivers of Degree of Rivalry in the Biotechnology Market in Canada, 2007 81
Figure 50: Canada Biotechnology Market Value Forecast: $ million, 2007-2012 82
Figure 51: China Biotechnology Market Value: $ million, 2003-2007 86
Figure 52: China Biotechnology Market Segmentation I: % Share, by Value, 2007 87
Figure 53: China Biotechnology Market Segmentation II: % Share, by Value, 2007 88
Figure 54: Forces Driving Competition in the Biotechnology Market in China, 2007 89
Figure 55: Drivers of Buyer Power in the Biotechnology Market in China, 2007 90
Figure 56: Drivers of Supplier Power in the Biotechnology Market in China, 2007 91
Figure 57: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in China, 2007 92
Figure 58: Factors Influencing the Threat of Substitutes in the Biotechnology Market in China, 2007 93
Figure 59: Drivers of Degree of Rivalry in the Biotechnology Market in China, 2007 94
Figure 60: China Biotechnology Market Value Forecast: $ million, 2007-2012 95
Figure 61: France Biotechnology Market Value: $ million, 2003-2007 99
Figure 62: France Biotechnology Market Segmentation I: % Share, by Value, 2007 100
Figure 63: France Biotechnology Market Segmentation II: % Share, by Value, 2007 101
Figure 64: Forces Driving Competition in the Biotechnology Market in France, 2007 102
Figure 65: Drivers of Buyer Power in the Biotechnology Market in France, 2007 103
Figure 66: Drivers of Supplier Power in the Biotechnology Market in France, 2007 104
Figure 67: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in France, 2007 105
Figure 68: Factors Influencing the Threat of Substitutes in the Biotechnology Market in France, 2007 106
Figure 69: Drivers of Degree of Rivalry in the Biotechnology Market in France, 2007 107
Figure 70: France Biotechnology Market Value Forecast: $ million, 2007-2012 108
Figure 71: Germany Biotechnology Market Value: $ million, 2003-2007 112
Figure 72: Germany Biotechnology Market Segmentation I: % Share, by Value, 2007 113
Figure 73: Germany Biotechnology Market Segmentation II: % Share, by Value, 2007 114
Figure 74: Forces Driving Competition in the Biotechnology Market in Germany, 2007 115
Figure 75: Drivers of Buyer Power in the Biotechnology Market in Germany, 2007 116
Figure 76: Drivers of Supplier Power in the Biotechnology Market in Germany, 2007 117
Figure 77: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Germany, 2007 118
Figure 78: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Germany, 2007 119
Figure 79: Drivers of Degree of Rivalry in the Biotechnology Market in Germany, 2007 120
Figure 80: Germany Biotechnology Market Value Forecast: $ million, 2007-2012 121
Figure 81: Italy Biotechnology Market Value: $ million, 2003-2007 125
Figure 82: Italy Biotechnology Market Segmentation I: % Share, by Value, 2007 126
Figure 83: Italy Biotechnology Market Segmentation II: % Share, by Value, 2007 127
Figure 84: Forces Driving Competition in the Biotechnology Market in Italy, 2007 128
Figure 85: Drivers of Buyer Power in the Biotechnology Market in Italy, 2007 129
Figure 86: Drivers of Supplier Power in the Biotechnology Market in Italy, 2007 130
Figure 87: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Italy, 2007 131
Figure 88: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Italy, 2007 132
Figure 89: Drivers of Degree of Rivalry in the Biotechnology Market in Italy, 2007 133
Figure 90: Italy Biotechnology Market Value Forecast: $ million, 2007-2012 134
Figure 91: Japan Biotechnology Market Value: $ million, 2003-2007 136
Figure 92: Japan Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Figure 93: Japan Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Figure 94: Forces Driving Competition in the Biotechnology Market in Japan, 2007 136
Figure 95: Drivers of Buyer Power in the Biotechnology Market in Japan, 2007 136
Figure 96: Drivers of Supplier Power in the Biotechnology Market in Japan, 2007 136
Figure 97: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Japan, 2007 136
Figure 98: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Japan, 2007 136
Figure 99: Drivers of Degree of Rivalry in the MARKET NAME in COUNTRY, 2007 136
Figure 100: Japan Biotechnology Market Value Forecast: $ million, 2007-2012 136
Figure 101: Netherlands Biotechnology Market Value: $ million, 2003-2007 136
Figure 102: Netherlands Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Figure 103: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Figure 104: Forces Driving Competition in the Biotechnology Market in the Netherlands, 2007 136
Figure 105: Drivers of Buyer Power in the Biotechnology Market in the Netherlands, 2007 136
Figure 106: Drivers of Supplier Power in the Biotechnology Market in the Netherlands, 2007 136
Figure 107: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in the Netherlands, 2007 136
Figure 108: Factors Influencing the Threat of Substitutes in the Biotechnology Market in the Netherlands, 2007 136
Figure 109: Drivers of Degree of Rivalry in the Biotechnology Market in the Netherlands, 2007 136
Figure 110: Netherlands Biotechnology Market Value Forecast: $ million, 2007-2012 136
Figure 111: Spain Biotechnology Market Value: $ million, 2003-2007 136
Figure 112: Spain Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Figure 113: Spain Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Figure 114: Forces Driving Competition in the Biotechnology Market in Spain, 2007 136
Figure 115: Drivers of Buyer Power in the Biotechnology Market in Spain, 2007 136
Figure 116: Drivers of Supplier Power in the Biotechnology Market in Spain, 2007 136
Figure 117: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Spain, 2007 136
Figure 118: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Spain, 2007 136
Figure 119: Drivers of Degree of Rivalry in the Biotechnology Market in Spain, 2007 136
Figure 120: Spain Biotechnology Market Value Forecast: $ million, 2007-2012 136
Figure 121: United Kingdom Biotechnology Market Value: $ million, 2003-2007 136
Figure 122: United Kingdom Biotechnology Market Segmentation I: % Share, by Value, 2007 136
Figure 123: United Kingdom Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Figure 124: Forces Driving Competition in the Biotechnology Market in the UK, 2007 136
Figure 125: Drivers of Buyer Power in the Biotechnology Market in the UK, 2007 136
Figure 126: Drivers of Supplier Power in the Biotechnology Market in the UK, 2007 136
Figure 127: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in the UK, 2007 136
Figure 128: Factors Influencing the Threat of Substitutes in the Biotechnology Market in the UK, 2007 136
Figure 129: Drivers of Degree of Rivalry in the Biotechnology Market in the UK, 2007 136
Figure 130: United Kingdom Biotechnology Market Value Forecast: $ million, 2007-2012 136
Figure 131: United States Biotechnology Market Value: $ million, 2003-2007 136
Figure 132: United States Biotechnology Market Segmentation I: % Share, by Volume, 2007 136
Figure 133: United States Biotechnology Market Segmentation II: % Share, by Value, 2007 136
Figure 134: Forces Driving Competition in the Biotechnology Market in the US, 2007 136
Figure 135: Drivers of Buyer Power in the Biotechnology Market in the US, 2007 136
Figure 136: Drivers of Supplier Power in the Biotechnology Market in the US, 2007 136
Figure 137: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in the US, 2007 136
Figure 138: Factors Influencing the Threat of Substitutes in the Biotechnology Market in the US, 2007 136
Figure 139: Drivers of Degree of Rivalry in the Biotechnology Market in the US, 2007 136
Figure 140: United States Biotechnology Market Value Forecast: $ million, 2007-2012 136
Figure 141: Revenues & Profitability: Amgen Inc. 136
Figure 142: Revenues & Profitability: Genentech, Inc. 136
Figure 143: Revenues & Profitability: Biogen Idec, Inc. 136
[Tabellenverzeichnis ausblenden]